Circulating tumor DNA (ctDNA) in human epidermal growth factor receptor 2-positive (HER2[+]) Early Breast Cancer (EBC): Translational analysis of PHERGain neoadjuvant tailored treatment study

This article has no abstract
Epistemonikos ID: 0d43fccabe7994486af4580f3bfe7bf5f86ccf3d
First added on: Jun 06, 2026